Correlation Between Praxis Precision and Spero Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Spero Therapeutics, you can compare the effects of market volatilities on Praxis Precision and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Spero Therapeutics.

Diversification Opportunities for Praxis Precision and Spero Therapeutics

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Praxis and Spero is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Praxis Precision i.e., Praxis Precision and Spero Therapeutics go up and down completely randomly.

Pair Corralation between Praxis Precision and Spero Therapeutics

Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 1.38 times more return on investment than Spero Therapeutics. However, Praxis Precision is 1.38 times more volatile than Spero Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.04 per unit of risk. If you would invest  4,521  in Praxis Precision Medicines on August 24, 2024 and sell it today you would earn a total of  2,785  from holding Praxis Precision Medicines or generate 61.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.21%
ValuesDaily Returns

Praxis Precision Medicines  vs.  Spero Therapeutics

 Performance 
       Timeline  
Praxis Precision Med 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Praxis Precision Medicines are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Praxis Precision showed solid returns over the last few months and may actually be approaching a breakup point.
Spero Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spero Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Praxis Precision and Spero Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Praxis Precision and Spero Therapeutics

The main advantage of trading using opposite Praxis Precision and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.
The idea behind Praxis Precision Medicines and Spero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk